Policlinico di Milano
Policlinico di Milano
Milan, Italy2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Virus Infections, Herpesviridae infectious disease, Infections, Nutritional and Metabolic Diseases, cytomegalovirus infection, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, inborn mitochondrial metabolism disorder, metabolic disease, multiple acyl-CoA dehydrogenase deficiency, viral infectious disease | Recruiting | Not stated | 2026-06-15 | NCT05234723 | |
| The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 3 | 2025-01-07 | NCT04803994 |